secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001493152-22-016803
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences appoints Mike Webb and Bevin O'Neil to board
----------------------------------------------------------------

- Appointed on June 13, 2022; terms expire at 2022 annual meeting or upon successor.
- Bevin O'Neil named to Audit Committee; Mike Webb named to Science and Technology Committee.
- No arrangements or transactions requiring disclosure under Reg S-K Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315222016803/0001493152-22-016803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315222016803/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-016803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer